This is the PDF eBook version for Molecular Determinants of Head and Neck Cancer 2nd Edition by Barbara Burtness, Erica A. Golemis
Table of Contents
Chapter 1: Overview: B. Burtness and E. Golemis
Chapter 2: HER inhibition in HNC: E. Golemis and B. Burtness
Chapter 3: MET: T Beck, Fox Chase Cancer Center
Chapter 4: PI3K/mTOR/AMPK: C. Chung, Moffit Cancer Center
Chapter 5: Jak/STAT: J.R. Grandis, UCSF
Chapter 6: TGFb: Neiman and Wang, University of Colorado
Chapter 7: Wnt and catenin Signaling: MA Kukurusinska, Boston University
Chapter 8: P53/p63/p73: B. Burtness
Chapter 9: DNA damage: R. Bindra, Yale University
Chapter 10: APOBEC Proteins: K.S. Anderson, Yale University
Chapter 11: Hypoxia, including HIF1: Q. Le, Stanford University
Chapter 12: VEGF/Angiogenesis and Antiangiogenic Therapy: A Argiris, Thomas Jefferson University
Chapter 13: Sequencing/genomic insights: J.Myers, MD Anderson
Chapter 14: Gene expression, Methylation, and histones: R.Mehra, A.Andrews, S.Peri, Fox Chase Cancer Center and A.Bhatia, Yale University
Chapter 15: Inflammation: Carter Van Waes, NIH
Chapter 16:Immunotherapy: Ferris and Baumann, UPMC
Chapter 17: FAK/Integrin pathway inhibitors: Nils Cordes, Dresden
Chapter 18: Targeting cell cycle controls: E.Golemis
Chapter 19: Head and neck cancer stem cells: L.Bourguignon, UCSF
Chapter 20: Non-coding RNAs: C.Punyadeera, Queensland University
Chapter 21: Epidemiology of HPV: Ragin and Lui, Fox Chase Cancer Center
Chapter 22: DNA damage in HPV-positive SCCHN: WG Yarbrough, Yale University
Chapter 23: Treatment paradigms in HPV-positive SCCHN: A Cmelak, Vanderbilt University